Antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) is a disease process characterised by necrosis and inflammatory damage to the blood vessels. In this interview, Prof Mårten Segelmark and Dr Onno Teng discuss the pathophysiology of these multifactorial diseases, treatment for which generally comprises immunosuppressive therapies and high dose glucocorticoids to help induce remission.
EMJ Nephrology 8 [Supplement 2] . 2020
June 2020
In this issue
Rate this content's potential impact on patient outcomes
Average rating / 5. Vote count:
No votes so far! Be the first to rate this content.
Thank you!
Please share some more information on the rating you have given